Epidemiological impact and cost-effectiveness of universal meningitis b vaccination among college students prior to college entry.

by Grace S Chung, David W Hutton
Published 2020-01-01

Cost-Effectiveness and Cost Thresholds of Generic and Brand Drugs in a National Chronic Hepatitis B Treatment Program in China.

by Mehlika Toy, David W Hutton, Samuel K So
Published 2015-01-01

Hitting the Optimal Vaccination Percentage and the Risks of Error: Why to Miss Right.

by Michael J Harvey, Lisa A Prosser, Mark L Messonnier, David W Hutton
Published 2016-01-01

Cost-effectiveness of the Adaptive Implementation of Effective Programs Trial (ADEPT): approaches to adopting implementation strategies

by Andria B. Eisman, David W. Hutton, Lisa A. Prosser, Shawna N. Smith, Amy M. Kilbourne
Published 2020-12-01

Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016–30

by David Tordrup, MSc, Yvan Hutin, MD, Karin Stenberg, MSc, Jeremy A Lauer, PhD, David W Hutton, PhD, Mehlika Toy, PhD, Nick Scott, PhD, Marc Bulterys, MD, Andrew Ball, MD, Gottfried Hirnschall, MD
Published 2019-09-01